Judge allows one final amendment of class action suit over Fabrazyme prescription drug shortage
PITTSBURGH – A federal judge has granted a final opportunity to amend a class action complaint, for plaintiffs who claimed significant harm was sustained on behalf of themselves and/or their loved ones, based on a shortage of a pharmaceutical drug named Fabrazyme that began in 2009 and lasted until 2012.
Source: pennrecord.com
:quality(70):focal(2005x522:2015x532)/cloudfront-eu-central-1.images.arcpublishing.com/irishtimes/4UNUMTV7WNFN3E6I6CNQ6S4Q5E.jpg)